Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0U4TY
|
||||
| Former ID |
DNC010609
|
||||
| Drug Name |
4-cycloheptyl-6-propylpyrimidine-2-carbonitrile
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530717] | ||
| Formula |
C15H21N3
|
||||
| Canonical SMILES |
CCCC1=NC(=NC(=C1)C2CCCCCC2)C#N
|
||||
| InChI |
1S/C15H21N3/c1-2-7-13-10-14(18-15(11-16)17-13)12-8-5-3-4-6-9-12/h10,12H,2-9H2,1H3
|
||||
| InChIKey |
UOAUUFFKQMFGTJ-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cathepsin S | Target Info | Inhibitor | [530717] | |
| Cathepsin K | Target Info | Inhibitor | [530717] | ||
| Reactome | Endosomal/Vacuolar pathway | ||||
| Degradation of the extracellular matrix | |||||
| Trafficking and processing of endosomal TLR | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
| Activation of Matrix Metalloproteinases | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.